WO2001055449A8 - Nucleic acids, proteins, and antibodies - Google Patents

Nucleic acids, proteins, and antibodies

Info

Publication number
WO2001055449A8
WO2001055449A8 PCT/US2001/001346 US0101346W WO0155449A8 WO 2001055449 A8 WO2001055449 A8 WO 2001055449A8 US 0101346 W US0101346 W US 0101346W WO 0155449 A8 WO0155449 A8 WO 0155449A8
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
antibodies
further relates
present
novel
Prior art date
Application number
PCT/US2001/001346
Other languages
French (fr)
Other versions
WO2001055449A1 (en
Inventor
Craig A Rosen
Steven C Barash
Steven M Ruben
Original Assignee
Human Genome Sciences Inc
Craig A Rosen
Steven C Barash
Steven M Ruben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Craig A Rosen, Steven C Barash, Steven M Ruben filed Critical Human Genome Sciences Inc
Priority to EP01916067A priority Critical patent/EP1255869A1/en
Priority to AU2001243135A priority patent/AU2001243135A1/en
Priority to CA002393941A priority patent/CA2393941A1/en
Priority to US09/860,670 priority patent/US20020165137A1/en
Publication of WO2001055449A1 publication Critical patent/WO2001055449A1/en
Publication of WO2001055449A8 publication Critical patent/WO2001055449A8/en
Priority to US10/227,646 priority patent/US20030235829A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to novel proteins. More specifically, isolated nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human polynucleotides and/or polypeptides, and antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides. The invention further relates to screening methods for identifiying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.
PCT/US2001/001346 2000-01-31 2001-01-17 Nucleic acids, proteins, and antibodies WO2001055449A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP01916067A EP1255869A1 (en) 2000-01-31 2001-01-17 Nucleic acids, proteins, and antibodies
AU2001243135A AU2001243135A1 (en) 2000-01-31 2001-01-17 Nucleic acids, proteins, and antibodies
CA002393941A CA2393941A1 (en) 2000-01-31 2001-01-17 Nucleic acids, proteins, and antibodies
US09/860,670 US20020165137A1 (en) 2000-01-31 2001-05-21 Nucleic acids, proteins, and antibodies
US10/227,646 US20030235829A1 (en) 2000-01-31 2002-08-26 Nucleic acids, proteins, and antibodies

Applications Claiming Priority (60)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US60/179,065 2000-01-31
US18062800P 2000-02-04 2000-02-04
US60/180,628 2000-02-04
US20551500P 2000-05-19 2000-05-19
US60/205,515 2000-05-19
US21688000P 2000-07-07 2000-07-07
US60/216,880 2000-07-07
US21829000P 2000-07-14 2000-07-14
US60/218,290 2000-07-14
US22544700P 2000-08-14 2000-08-14
US60/225,447 2000-08-14
US22934300P 2000-09-01 2000-09-01
US60/229,343 2000-09-01
US23043700P 2000-09-06 2000-09-06
US60/230,437 2000-09-06
US23124300P 2000-09-08 2000-09-08
US60/231,243 2000-09-08
US23499700P 2000-09-25 2000-09-25
US60/234,997 2000-09-25
US23636700P 2000-09-29 2000-09-29
US60/236,367 2000-09-29
US23993700P 2000-10-13 2000-10-13
US60/239,937 2000-10-13
US24652800P 2000-11-08 2000-11-08
US24652600P 2000-11-08 2000-11-08
US24652500P 2000-11-08 2000-11-08
US24647700P 2000-11-08 2000-11-08
US24647600P 2000-11-08 2000-11-08
US60/246,525 2000-11-08
US60/246,476 2000-11-08
US60/246,528 2000-11-08
US60/246,477 2000-11-08
US60/246,526 2000-11-08
US24921000P 2000-11-17 2000-11-17
US24921100P 2000-11-17 2000-11-17
US24926500P 2000-11-17 2000-11-17
US24921400P 2000-11-17 2000-11-17
US60/249,211 2000-11-17
US60/249,265 2000-11-17
US60/249,214 2000-11-17
US60/249,210 2000-11-17
US25039100P 2000-12-01 2000-12-01
US25016000P 2000-12-01 2000-12-01
US60/250,391 2000-12-01
US60/250,160 2000-12-01
US25198800P 2000-12-05 2000-12-05
US25671900P 2000-12-05 2000-12-05
US25103000P 2000-12-05 2000-12-05
US60/251,988 2000-12-05
US60/251,030 2000-12-05
US60/256,719 2000-12-05
US25147900P 2000-12-06 2000-12-06
US60/251,479 2000-12-06
US25198900P 2000-12-08 2000-12-08
US25199000P 2000-12-08 2000-12-08
US60/251,990 2000-12-08
US60/251,989 2000-12-08
US25409700P 2000-12-11 2000-12-11
US60/254,097 2000-12-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/860,670 Continuation-In-Part US20020165137A1 (en) 2000-01-31 2001-05-21 Nucleic acids, proteins, and antibodies

Publications (2)

Publication Number Publication Date
WO2001055449A1 WO2001055449A1 (en) 2001-08-02
WO2001055449A8 true WO2001055449A8 (en) 2001-09-07

Family

ID=27586881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/001346 WO2001055449A1 (en) 2000-01-31 2001-01-17 Nucleic acids, proteins, and antibodies

Country Status (3)

Country Link
EP (1) EP1255869A1 (en)
CA (1) CA2393941A1 (en)
WO (1) WO2001055449A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178458A1 (en) * 2003-09-05 2007-08-02 O'brien Philippa Methods of diagnosis and prognosis of ovarian cancer II

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955309A (en) * 1997-06-18 1999-09-21 Smithkline Beecham Corporation Polynucleotide encoding G-protein coupled receptor (H7TBA62)

Also Published As

Publication number Publication date
EP1255869A1 (en) 2002-11-13
WO2001055449A1 (en) 2001-08-02
CA2393941A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
WO2001055309A8 (en) Nucleic acids, proteins, and antibodies
WO2001090304A3 (en) Nucleic acids, proteins, and antibodies
WO2001054472A3 (en) Nucleic acids, proteins, and antibodies
WO2001055306A3 (en) Nucleic acids, proteins, and antibodies
WO2001055326A8 (en) Nucleic acids, proteins, and antibodies
WO2001055440A8 (en) Nucleic acids, proteins, and antibodies
WO2001055168A8 (en) Nucleic acids, proteins and antibodies
WO2002072763A3 (en) Nucleic acids, proteins, and antibodies
WO2001055167A8 (en) Nucleic acids, proteins, and antibodies
WO2001055449A8 (en) Nucleic acids, proteins, and antibodies
WO2001055162A8 (en) Nucleic acids, proteins, and antibodies
WO2001055305A3 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED", ADD "WITH SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU."

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2393941

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001916067

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001916067

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001916067

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)